Richard Webster

Investigator, CHEO Research Institute

Dr. Richard Webster is the Scientific Director of the Clinical Research Unit (CRU) at the CHEO Research Institute, where he oversees a pediatric methodology unit, consisting of ~15 biostatisticians, epidemiologists and qualitative researchers. Richard co-leads the OCHSU (Ontario Child Health Support Unit) in efforts to accelerate patient-centered child health research.

As an associate scientist and adjunct professor at CHEO and the University of Ottawa’s Telfer School of Management, his research program focuses on climate friendly health systems. He catalyzed CHEO becoming the first Canadian hospital to set a board approved net-zero target. Richard is on the governance and scientific expert committee for SOSCHI (Standards for Official Statistics on Climate-Health Interactions) and an active member of the Cochrane Planetary Health Thematic Group.

Related News

Research Projects

  1. Real-time detection of neonatal seizures improves with on demand EEG interpretation

    11/11/2022

    Combining aEEG with on-demand cEEG interpretation improved accurate seizure detection in a high-risk NICU population, with the potential to avoid over-treatment.

  2. Development and validation of a Fast Spine Protocol for Use in Paediatric Patients

    23/08/2022

    This study demonstrates that selected spinal imaging sequences allows for consistent and accurate diagnosis of specific clinical conditions. A limited spine protocol reduces acquisition time, potentially avoiding sedation. Further work is needed to determine the utility of selected imaging for other clinical indications.

  3. Nasopharyngeal swabs vs. saliva sampling for SARS-CoV-2 detection: A cross-sectional survey of acceptability for caregivers and children after experiencing both methods

    08/07/2022

    Though most youth find saliva sampling painless and prefer it to nasopharyngeal swabs, primary decision makers present for the experience generally remain accepting of both methods for COVID-19 testing.

  4. Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study

    15/05/2022

  5. Protecting human health in a time of climate change: how Cochrane should respond

    30/03/2022